JohnPaulMiddletonMD

Nephrology • Durham, NC

Physician

Join to view full profile

Dr. Middleton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Middleton's full profile

Already have an account?

Office
2100 Erwin Rd
Durham, NC 27705
Phone+1 919-620-4467

Fax+1 919-681-1143

Education & Training

Duke University HospitalFellowship, Nephrology, 1989
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 1983 - 1986
Virginia Commonwealth University School of MedicineClass of 1983, MD

Certifications & Licensure

NC State Medical License 1986 - 2025
TX State Medical License 1996 - 2003
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Clinical Trials

Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Start of enrollment: 2013 Mar 18
Terminated
Phase 2
Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients Start of enrollment: 2019 Jun 20
Completed
Phase 4
The Arteriovenous Vascular (AV) ACCESS Trial Start of enrollment: 2022 Aug 18
Recruiting
Not Applicable

Publications & Presentations

PubMed

Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US Nephrologists.
Anjay Rastogi, Glenn M Chertow, Ashté Collins, Ellie Kelepouris, Wayne Kotzker
Advances in Kidney Disease and Health. 2024-11-01
1 citations
Randomized Trial of Patiromer on Efficacy to Reduce Episodic Hyperkalemia in Patients with ESKD Treated With Hemodialysis.
John P Middleton, Shifeng Sun, Susan Murray, Clemontina A Davenport, James P Daubert
Kidney International Reports. 2024-11-01
1 citations
Effects of dialysate potassium concentration of 3.0mEq/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0mEq/l...
David M Charytan, Wolfgang C Winkelmayer, Christopher B Granger, John P Middleton, Charles A Herzog
Kidney International. 2024-10-26

Grant Support

African American Study Of Kidney Disease And HypertensionNational Center For Research Resources1997–2002
Medical Maintenance Of Hemodialysis Vascular AccessNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2001
Effect Of Alpha MSH On InflammationNational Center For Research Resources2000
Development Of Renal Function Test--Para Aminohippurate Excretion TestNational Center For Research Resources2000
African American Study Of Kidney Disease &HypertensionNational Center For Research Resources2000
African American Study Of Kidney Disease And HypertensioNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2000